Efficacy of atomoxetine in children with severe autistic disorders and symptoms of ADHD: An open-label study

Journal of Attention Disorders

Volumn 15, Issue 8, 2011, Pages 684-689

  Charnsil, Chawanun ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

atomoxetine; attention; autistic; hyperactivity

Indexed keywords

ATOMOXETINE; CENTRAL STIMULANT AGENT; PROPYLAMINE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CHILD; FEMALE; HUMAN; MALE; PILOT STUDY; TREATMENT OUTCOME;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; HUMANS; MALE; PILOT PROJECTS; PROPYLAMINES; TREATMENT OUTCOME;

EID: 82455167368     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054710376907     Document Type: Article

References (24)

1. Aman M.G.,Buican B.,Arnold L.E.Methylphenidate treatment in children with borderline IQ and mental retardation: Analysis of three aggregated studies.Journal of Child and Adolescent Psychopharmacology. 2003;13:29-40.
2. Aman M.G.,Singh N.N.,Stewart A.W.,Field C.J.The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects.American Journal of Mental Deficiency. 1985;89:485-491.
3. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorder (4th ed., text rev.). Washington, DC: Author.
4. Arnold L.E.,Aman M.G.,Cook A.M.,Witwer A.N.,Hall K.L.,Thompson S.,Ramadan Y.Atomoxetine for hyperactivity in autism spectrum disorders: Placebo-controlled crossover pilot trial.Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45:10.
5. Biederman J.,Heiligenstein J.H.,Faries D.E.,Galil N.,Dittmann R.,Emslie G.J.Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder.Pediatrics. 2002;110:e75.
6. Buitelaar, J. K., Danckaerts, M., Gillberg, C., Zuddas, A., Becker, K., Bouvard, M., . . . Michelson, D. (2004). A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD. European Child & Adolescent Psychiatry, 13, 249-257.
7. Cheng J.,Chen R.,Ko J.,Ng E.Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-Meta-analysis and meta-regression analysis.Psychopharmacology. 2007;194:197-209.
8. Eaves R.,Milner B.The criterion-related validity of the Childhood Autism Rating Scale and the Autism Behavior Checklist.Journal of Abnormal Child Psychology. 1993;21:481-491.
9. Escobar R.,Soutullo C.,San Sebastian J.,Ferneandez E.,Julian I.,Lahortiga F.Atomoxetine safety and efficacy in children with attention deficit/hyperactivity disorder (ADHD): Initial phase of 10-week treatment in a relapse prevention study with a Spanish sample.Actas Españolas de Psiquiatría. 2005;33:26-32.
10. Goldstein S.,Schwebach A.J.The co-morbidity of pervasive developmental disorder and attention deficit hyperactivity disorder: Results of a retrospective chart review.Journal of Autism and Developmental Disorders. 2004;34:329-339.
11. Handen B.L.,Johnson C.R.,Lubetsky M.Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.Journal of Autism and Developmental Disorders. 2000;30:245-255.
12. Kelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., . . . Allen, A. J. (2004). Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blinded, placebo-controlled trial. Pediatrics, 114, e1-8.
13. Lecavalier L.Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification.Journal of Autism and Developmental Disorders. 2006;36:1101-1114.
14. Magyar C.,Pandolfi V.Factor structure evaluation of the Childhood Autism Rating Scale.Journal of Autism and Developmental Disorders. 2007;37:1787-1794.
15. Michelson D.,Faries D.,Wernicke J.,Kelsey D.,Kendrick K.,Sallee F.R.,Spencer T.Atomoxetine study group: Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized placebo-controlled, dose-response study.Pediatrics. 2001;108:e83.
16. Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvl, C., . . . . West, S. (2002). Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. American Journal of Psychiatry, 159, 1896-1900.
17. Michelson, D., Buitelaar, J. K., Danckaerts, M., Gillberg, C., Spencer, T. J., Zuddar, A., . . . . Biederman, J. (2004). Relapse prevention in pediatric patients with ADHD treated with atomoxetine: A randomized double-blinded, placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 896-940.
18. Posey D.J.,Wiegand R.E.,Wilkerson J.,Maynard M.,Stigler K.A.,McDougle C.J.Open-label atomoxetine for attention-deficit/hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.Journal of Child and Adolescent Psychopharmacology. 2006;16:599-610.
19. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorder with hyperactivity.Archives of General Psychiatry. 2005;62:1266-1274.
20. Saemundsen E.,Magnusson P.,Smari J.,Sigurdardottiri S.Autism Diagnostic Interview-Revised and the Childhood Autism Rating Scale: Convergence and discrepancy in diagnosing autism.Journal of Autism and Developmental Disorders. 2003;33:319.
21. Sinzig J.,Walter D.,Doepfner M.Attention deficit/hyperactivity disorder in children and adolescents with autism spectrum disorder: Symptoms or syndrome?.Journal of Attention Disorders. 2009;13:117-126.
22. Spencer T.J.,Biederman J.,Wilens T.E.,Faraone S.V.Overview and neurobiology of attention-deficit/hyperactivity disorder.Journal of Clinical Psychiatry. 2002;26:3-9.
23. Teal MB,Wiebe MJ.A validity analysis of selected instruments used to assess autism.J Autism Dev Disord. 1986;16 (4): 485-94.
24. Troost P.W.,Steenhuis M.-P.,Tuynman-Qua H.G.,Kalverdijk L.J.,Buitelaar J.K.,Minderaa R.B.,Hoekstra P.J.Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: A pilot study.Journal of Child and Adolescent Psychopharmacology. 2006;16:611-619.